Therapeutic continuity in Alzheimer's disease: switching patients to galantamine. Panel discussion: recommendations for prescribers

Clin Ther. 2001:23 Suppl A:A31-9. doi: 10.1016/s0149-2918(01)80166-1.
No abstract available

MeSH terms

  • Aged
  • Alzheimer Disease / drug therapy*
  • Cholinesterase Inhibitors / therapeutic use*
  • Galantamine / therapeutic use*
  • Humans

Substances

  • Cholinesterase Inhibitors
  • Galantamine